The U.S. Cannabis Export Window Is Open — But Only for Those Who Can Clear the Bar

For years, U.S. cannabis operators have been the most sophisticated in the world, building brands and scaling operations, all inside a market with no exit to the outside world. That changed with the reclassification of cannabis to Schedule III under the Controlled Substances Act, which for the first time created a federal framework for international trade.

The pathway is not simple. Operators will need DEA registration, export permits, and compliance with the laws of importing countries. But those are legal processes, not locked doors, and in markets like the U.K., Germany, Australia, and Israel, where medical cannabis demand is established and growing, U.S. companies are now eligible to compete.

“The most relevant models are federally controlled medical cannabis frameworks that operate through national licensing, import-export permits, and quota systems,” Paula Savchenko, founding partner of Cannacore Group and PS Law Group, said in an interview with IgniteIt.

Legal and industry experts all agree that the policy change signals federal recognition of cannabis’ medical value. However, it falls short of unlocking recreational cannabis, which remains in Schedule I, as well as broad interstate or international trade.

“While it is a significant federal shift, it is still limited in scope,” Savchenko said.

Federal Cannabis Shift Stops Short Of Unlocking Interstate Commerce, Expert Explains Why

“The biggest misconception is that Schedule III automatically unlocks interstate commerce and international exports. It does not,” Savchenko said.

She emphasized the cannabis industry remains within a “controlled-substances framework.” Meaning, any movement of cannabis across state lines or borders requires approvals, from DEA registration to export permits, treaty compliance, and authorization from importing countries.

For cannabis companies to take their fair share in cross-border trade, a long list of requirements is needed. “In practice, international trade will not be automatic. Operators will need to navigate DEA registration, DEA permitting, treaty obligations, foreign-country licensing, product eligibility, and state-law limitations before any lawful export activity can occur,” Savchenko explained.

Looking Abroad For Roadmap

Nevertheless, the U.S. cannabis operators looking for clues about the future of cross-border trade should turn to markets like Canada, Germany, the United Kingdom, Australia, Portugal, and Israel as these are already parts of the global medical cannabis trade ecosystem, Savchenko said.

“The most relevant models are not adult-use markets, but federally controlled medical cannabis frameworks that operate through national licensing, import/export permits, quota systems, and medical or scientific use limitations,” she said. “Those systems may offer insight into how the U.S. framework could develop if DEA registration and export permitting become functional pathways.”

Canada stands out as a mature cannabis exporter, with a federally regulated system that enables international shipments under strict rules. However, cost remains an issue.

“Canadian cannabis is generally more expensive to cultivate than product grown in lower-cost jurisdictions,” Savchenko continued. “Its advantage is largely reputational: in many markets, ‘Canadian cannabis’ is still viewed favorably from a quality and consistency perspective.”

In Europe, Germany and the United Kingdom are leaders, relying on imports and distributor-led market entry.

Savchenko pointed out that Germany is “probably the most relevant medical cannabis market in Europe,” as it “has helped shape how medical cannabis is imported, prescribed, and distributed,” influencing the regulatory landscape in Europe. Meanwhile, Portugal and Malta, which specialize in EU-GMP processing and distribution of products grown in lower-cost regions, serve as supply chain hubs.

Australia and Israel provide examples of tightly regulated systems with established import-export channels, Savchenko said, adding operators are also eyeing emerging players such as Colombia, South Africa, Morocco, Greece, and North Macedonia.